282 related articles for article (PubMed ID: 1584598)
1. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
[TBL] [Abstract][Full Text] [Related]
2. [Effect of female sex hormones on blastic transformation of lymphocytes in systemic lupus erythematosus and in healthy women].
Pozsonyi T; Jakab L; Gonzalez-Cabello R; Cao VV; Cseh K; Kalabay L; Marticsek J; Gergely P; Jakab L
Orv Hetil; 1987 Dec; 128(51):2677-8, 2681-2. PubMed ID: 3324000
[TBL] [Abstract][Full Text] [Related]
3. The effect of the alpha 2-HS-glycoprotein on the mitogen-induced lymphoblastic transformation and IL-2 production.
Jakab L; Jakab L; Kalabay L; Pozsonyi T; Cseh K
Acta Physiol Hung; 1991; 77(1):25-31. PubMed ID: 1950589
[TBL] [Abstract][Full Text] [Related]
4. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
5. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
Sierakowski S; Kucharz EJ
Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
[TBL] [Abstract][Full Text] [Related]
6. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
7. Independence of depressed lectin-dependent cell-mediated cytotoxicity from interleukin 2 production in patients with systemic lupus erythematosus.
Perl A; González-Cabello R; Onody K; Bodó I; Gergely P
Clin Exp Immunol; 1986 Aug; 65(2):286-92. PubMed ID: 3491706
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus.
Linker-Israeli M; Quismorio FP; Horwitz DA
J Rheumatol; 1988 Aug; 15(8):1216-22. PubMed ID: 2972835
[TBL] [Abstract][Full Text] [Related]
9. T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.
Draeger AM; Swaak AJ; van den Brink HG; Aarden LA
Clin Exp Immunol; 1986 Apr; 64(1):80-7. PubMed ID: 3488149
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
11. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.
McKenna RM; Wilkins JA; Warrington RJ
J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712
[TBL] [Abstract][Full Text] [Related]
13. The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.
Smith G; Morrison CA; Maddison PJ
Clin Exp Immunol; 1987 Jun; 68(3):552-61. PubMed ID: 2958189
[TBL] [Abstract][Full Text] [Related]
14. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D
Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
[TBL] [Abstract][Full Text] [Related]
15. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive therapy and systemic lupus erythematosus.
Travers RL; Hughes GR
J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
19. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).
Linker-Israeli M; Bakke AC; Kitridou RC; Gendler S; Gillis S; Horwitz DA
J Immunol; 1983 Jun; 130(6):2651-5. PubMed ID: 6222112
[TBL] [Abstract][Full Text] [Related]
20. [IL-2 production by peripheral blood mononuclear cells after stimulation with pokeweed mitogen].
Reinhold D; Ansorge S
Allerg Immunol (Leipz); 1990; 36(4):293-8. PubMed ID: 2097899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
